Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fuchs

Showing results (291-300 of 373) with videos related to

Pageof 38
Sort By:
Journal of Lipid Research|March 26, 2023
Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver diseaseKei Minowa, Daniel Rodriguez-Agudo, Mitsuyoshi Suzuki, et al.
Blood Advances|June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaSimon Leiders, Dominic Ufton, Helen Kaul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trialsBoris Böll, Helen Görgen, Michael Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study GroupStephanie Sasse, Helen Goergen, Annette Plütschow, et al.
Advances in Radiation Oncology|March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern EraMichael Oertel, Dominik Hering, Nina Nacke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study GroupStefanie Kreissl, Horst Müller, Helen Goergen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2016
Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple ComorbiditiesSamuel B Ho, Alexander Monto, Adam Peyton, et al.
Infection|February 19, 2022
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphomaAnne Sophie Jacob, Helen Kaul, Michael Fuchs, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Hepatology (Baltimore, Md.)|August 1, 2018
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal HypertensionGuadalupe Garcia-Tsao, Michael Fuchs, Mitchell Shiffman, et al.
Pageof 38

Showing results (291-300 of 373) with videos related to

Sort By:
Pageof 38
Journal of Lipid Research|March 26, 2023
Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver diseaseKei Minowa, Daniel Rodriguez-Agudo, Mitsuyoshi Suzuki, et al.
Blood Advances|June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaSimon Leiders, Dominic Ufton, Helen Kaul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trialsBoris Böll, Helen Görgen, Michael Fuchs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study GroupStephanie Sasse, Helen Goergen, Annette Plütschow, et al.
Advances in Radiation Oncology|March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern EraMichael Oertel, Dominik Hering, Nina Nacke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study GroupStefanie Kreissl, Horst Müller, Helen Goergen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2016
Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple ComorbiditiesSamuel B Ho, Alexander Monto, Adam Peyton, et al.
Infection|February 19, 2022
Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphomaAnne Sophie Jacob, Helen Kaul, Michael Fuchs, et al.
British Journal of Haematology|September 14, 2021
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trialElena Gerhard-Hartmann, Helen Goergen, Paul J Bröckelmann, et al.
Hepatology (Baltimore, Md.)|August 1, 2018
Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal HypertensionGuadalupe Garcia-Tsao, Michael Fuchs, Mitchell Shiffman, et al.
Pageof 38